[Market Focus] Noel Surges on AI Malaria Diagnostic Solution...Hits Record High

Noel is showing strong performance in early trading.

As of 9:05 a.m. on September 18, Noel was trading at 3,965 won, up 9.53% (345 won) from the previous day. During the session, the price soared to 4,110 won, setting a new 52-week high.

Investor sentiment appears to have been boosted by news that the company attracted market attention by presenting its artificial intelligence (AI)-based diagnostic solution at the 'APEC Health-Economy High-Level Meeting and 2025 World Bio Summit,' which was co-hosted by the Ministry of Health and Welfare and the World Health Organization (WHO).

At the annual forum of the Right Foundation, held on September 16 as part of the World Bio Summit, Noel took the stage to introduce the application cases and achievements of 'miLab MAL,' an AI malaria diagnostic solution that enables rapid and accurate testing even in low- and middle-income countries or resource-limited settings.

miLab MAL is an AI-based innovative diagnostic technology that addresses the limitations of conventional diagnostic systems, such as reliance on skilled personnel and infrastructure, high costs, and low accuracy.

Earlier this year, in a joint study with Labcorp, the largest diagnostic lab chain in the United States, miLab MAL achieved 100% sensitivity and specificity, earning recognition for its top-tier performance among advanced countries.

This content was produced with the assistance of AI translation services.